Altria Group (MO) Tops Q2 EPS by 5c
Get Alerts MO Hot Sheet
Price: $43.54 +1.44%
Revenue Growth %: -0.8%
Financial Fact:
Marketing, administration and research costs: 766M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Revenue Growth %: -0.8%
Financial Fact:
Marketing, administration and research costs: 766M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Altria Group (NYSE: MO) reported Q2 EPS of $1.23, $0.05 better than the analyst estimate of $1.18. Revenue for the quarter came in at $5.61 billion versus the consensus estimate of $5.4 billion.
GUIDANCE:
Altria Group sees FY2021 EPS of $4.56-$4.62, versus the consensus of $4.59.
- Altria narrows its guidance for 2021 full-year adjusted diluted EPS to be in a range of $4.56 to $4.62, representing a growth rate of 4.5% to 6% from an adjusted diluted EPS base of $4.36 in 2020. This range includes the estimated impact of the recently announced Ste. Michelle Transaction, which is expected to close in the second half of 2021. While the 2021 full-year adjusted diluted EPS guidance accounts for a range of scenarios, the external environment remains dynamic. Altria will continue to monitor conditions related to (i) the economy (including unemployment rates and the impact of increased inflation), (ii) fiscal stimulus, (iii) ATC dynamics, including stay-at-home practices, disposable income, purchasing patterns and adoption of smoke-free products, (iv) regulatory and legislative (including excise tax) developments, (v) the timing and extent of COVID-19 vaccine administration and the impact of COVID-19 variants and (vi) expectations for adjusted earnings contributions from its alcohol assets.
- Altria’s 2021 full-year adjusted diluted EPS guidance range includes planned investments in support of its Vision, such as (i) marketplace investments to expand the availability and awareness of Altria’s smoke-free products, (ii) costs associated with building an industry-leading consumer engagement platform that enhances data collection and insights in support of ATC transition to smoke-free products and (iii) increased smoke-free product research and development expense. The full-year adjusted diluted EPS guidance range excludes the special items for the first six months of 2021 shown in Table 1 and the charge that Altria will record in the second half of 2021, which Altria does not expect to be material to its financial statements, related to the Ste. Michelle Transaction.
- Altria continues to expect its 2021 full-year adjusted effective tax rate will be in a range of 24.5% to 25.5%.
For earnings history and earnings-related data on Altria Group (MO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Arca Biopharma (ABIO) Reports Q1 Loss of $0.14
- Employers Holdings (EIG) Misses Q1 EPS by 2c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!